Ovid Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.66 |
0.32 |
0.33 |
0.30 |
2.27 |
20.64 |
| Przychód Δ r/r |
0.00% |
-52.02% |
3.65% |
-9.18% |
659.69% |
807.51% |
| Przychód (min) |
0.53 |
0.20 |
0.32 |
0.16 |
1.19 |
10.80 |
| Przychód (max) |
0.76 |
0.44 |
0.33 |
0.46 |
3.52 |
31.91 |
| EBITDA (średnia) |
-0.45 |
-0.22 |
-0.22 |
-0.20 |
-1.55 |
-14.05 |
| EBIT (średnia) |
-0.45 |
-0.22 |
-0.22 |
-0.20 |
-1.55 |
-14.05 |
| EBIT % |
-68.08% |
-68.08% |
-68.08% |
-68.08% |
-68.08% |
-68.08% |
| Zysk netto (średni) |
-32.97 |
-43.93 |
-52.83 |
-71.63 |
-74.92 |
-55.31 |
| Zysk netto % |
-4975.07% |
-13815.33% |
-16029.98% |
-23928.53% |
-3294.78% |
-268.00% |
| EPS (średnia) |
-0.47 |
-0.62 |
-0.65 |
-0.90 |
-1.06 |
-0.78 |
| Liczba analityków (Przychody) |
7 |
5 |
5 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
5 |
4 |
4 |
4 |
3 |
2 |
| symbol |
OVID |
OVID |
OVID |
OVID |
OVID |
OVID |